A Haynes and Boone, LLP deal team represented VBI Vaccines Inc. in two transactions in recent months that raised funds to support the development of next-generation infectious disease and immuno-oncology vaccines.
Most recently, Haynes and Boone represented VBI Vaccines, a Cambridge, Mass.-based biopharmaceutical company, in securing a debt financing facility for up to $50 million with K2 HealthVentures (K2HV), a healthcare-focused specialty finance company. The deal was announced May 27, 2020.
The Haynes and Boone deal team previously represented VBI Vaccines in a $57.5 million common share offering, which closed on April 27, 2020.
New York Partner Rick Werner, co-chair of Haynes and Boone’s Capital Markets and Securities Practice Group, together with Greg Kramer, the co-chair of the New York Capital Markets and Securities Practice Group and Jayun Koo, a Partner in the New York Capital Markets and Securities Practice Group, led the team representing VBI in these matters. They were assisted by Associates Eloise Rotenberg, So Yung Kang and Maudess Fulton.
The Capital Markets and Securities Practice Group delivers strategic solutions and provides comprehensive advice on a full range of securities transactions and reporting matters. The group has helped companies raise capital and comply with evolving securities laws and practices for more than four decades, and it serves as securities counsel to more than 30 public companies ranging in size from small cap companies to large cap multi-national business entities.
Haynes and Boone is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services across a wide array of industries. With more than 575 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel single out for providing superior client service.